Voyageursp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-04-21
Share capital
45,000.00 PLN
Registered address
ul. Gen. Józefa Hallera 39, 07-410 Ostrołęka, Poland

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 140 days early.

  • 202530/03/2026
  • 202420/02/2025
  • 202321/03/2024
  • 202215/03/2023
  • 202104/03/2022
  • 202015/03/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.33mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 15.51kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 1.31mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 196.68kMedianUSD 544.32kAverageUSD 1.76m

Authorized Representatives

Adam Kulawik – Management Board Member
Anna Agata Kleczkowska – Management Board Member
Janusz Ryszard Kulawik – President of the Management Board
Patrycja Kulawik – Management Board Member

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Anna Agata Kleczkowskaage 59
18$2,431.1220%
Adam Kulawikage 34
18$2,431.1220%
Janusz Ryszard Kulawikage 69
36$4,862.2440%
Patrycja Kulawikage 34
18$2,431.1220%

Janusz Ryszard Kulawik, Adam Kulawik and Patrycja Kulawik hold a combined 80% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-05-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $33,021.

PurposeGross amount
Aid for microenterprises in the form of public interventions concerning electricity, gas or heat supplies
$62
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,769
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,750

Competitors

Name
DR ZdrowieS.A.
MagmaxS.A.
Adpharmasp. z o.o.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

FAQ

Last updated: 2026-03-31